Kailera Therapeutics
Latest round
- Series B
Last raised
- Oct 2025
Total raised
- $800M
Investors
- 14
About Kailera Therapeutics
Founded in 2024 and based in Massachusetts, US, Kailera Therapeutics, Inc. is a clinical-stage biopharmaceutical company. In October 2025, Kailera Therapeutics, Inc. Kailera Therapeutics focuses on developing treatments for obesity and weight-related conditions. The company’s pipeline includes a diverse range of therapies like KAI-9531, a dual GLP-1/GIP receptor agonist investigated for obesity and type 2 diabetes; KAI-7535, an oral GLP-1 receptor agonist targeting obesity and type 2 diabetes; and KAI-4729, a tri-agonist targeting GLP-1, GIP, and glucagon receptors for the treatment of obesity and type 2 diabetes. These therapies leverage various mechanisms of action, including GLP-1/GIP receptor dual agonists, GLP-1 receptor agonists, and GLP-1/GIP/Glucagon receptor tri-agonists.
Who invested in Kailera Therapeutics
14 investors across 2 rounds
See all investors in Kailera Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Kailera Therapeutics
Who invested in Kailera Therapeutics?
Kailera Therapeutics has 14 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Kailera Therapeutics raised?
Kailera Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Kailera Therapeutics last raise money?
Kailera Therapeutics's most recent round on record is a Series B, in Oct 2025.
What does Kailera Therapeutics do?
Founded in 2024 and based in Massachusetts, US, Kailera Therapeutics, Inc.
Where is Kailera Therapeutics headquartered?
Kailera Therapeutics is headquartered in Waltham, US.
Which VCs invest in companies like Kailera Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Kailera Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Kailera Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.